Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Crouzon syndrome is an autosomal dominant condition primarily characterized by craniosynostosis. This syndrome has been associated with a variety of amino acid point mutations in the extracellular domain of fibroblast growth factor receptor 2 (FGFR2). FGFR2/Neu chimeras were generated by substituting the extracellular domain of Neu with that of FGFR2 containing the following Crouzon mutations: Tyr-340-->His; Cys-342-->Tyr; Cys-342-->Arg; Cys-342-->Ser; Ser-354-->Cys: and delta17 (deletion of amino acids 345-361). Each of the mutant chimeric FGFR2/Neu constructs stimulated focus formation in NIH 3T3 cells, indicating that Crouzon mutations can stimulate signal transduction through a heterologous receptor tyrosine kinase. In vitro kinase assay results indicate that FGFR2 receptors containing Crouzon mutations have increased tyrosine kinase activity and, when analyzed under nonreducing conditions, exhibited disulfide-bonded dimers. Thus the human developmental abnormality Crouzon syndrome arises from constitutive activation of FGFR2 due to aberrant intermolecular disulfide-bonding. These results together with our earlier observation that achondroplasia results from constitutive activation of the related receptor FGFR3, leads to the prediction that other malformation syndromes attributed to FGFRs, such as Pfeiffer syndrome and Thanatophoric dysplasia, also arise from constitutive receptor activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614
Cited by
Ornitz, D. M., & Marie, P. J. (2002) · Genes & Development · doi:10.1101/gad.990702 · Cited by 905
Beyond GWASs: Illuminating the Dark Road from Association to Function
Edwards, S. L., Beesley, J., French, J. D., & Dunning, A. M. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.10.012 · Cited by 784
Structural basis for fibroblast growth factor receptor activation
Mohammadi, M., Olsen, S. K., & Ibrahimi, O. A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.008 · Cited by 735
Cranial sutures as intramembranous bone growth sites
Opperman, L. A. (2000) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1073>3.0.co;2-f · Cited by 645
Evers, R., Kool, M., van Deemter, L., Janssen, H., Calafat, J., Oomen, L. C., Paulusma, C. C., Oude Elferink, R. P., Baas, F., Schinkel, A. H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119886 · Cited by 620
Craniosynostosis: genes and mechanisms
Wilkie, A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.10.1647 · Cited by 529
Siegel, P. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2149 · Cited by 442
Kim, H.-J., Rice, D. P. C., Kettunen, P. J., & Thesleff, I. (1998) · Development · doi:10.1242/dev.125.7.1241 · Cited by 412
Integration of FGF and TWIST in calvarial bone and suture development
Rice, D. P. C., Åberg, T., Chan, Y.-S., Tang, Z., J. Kettunen, P., Pakarinen, L., Maxson, R. E., & Thesleff, I. (2000) · Development · doi:10.1242/dev.127.9.1845 · Cited by 407
Vajo, Z., Francomano, C. A., & Wilkin, D. J. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0387 · Cited by 350
Mansukhani, A., Bellosta, P., Sahni, M., & Basilico, C. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.6.1297 · Cited by 295
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
Hart, K. C., Robertson, S. C., Kanemitsu, M. Y., Meyer, A. N., Tynan, J. A., & Donoghue, D. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203650 · Cited by 276
Self-citationDepew, M. J., Tucker, A. S., & Sharpe, P. T. (2002) · Mouse Development · doi:10.1016/b978-012597951-1/50023-8 · Cited by 259
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
Yu, K., Herr, A. B., Waksman, G., & Ornitz, D. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14536 · Cited by 258
Kim, H.-J., Kim, J.-H., Bae, S.-C., Choi, J.-Y., Kim, H.-J., & Ryoo, H.-M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m203750200 · Cited by 236
Ibrahimi, O. A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh011 · Cited by 128
Evidence for digenic inheritance in some cases of Antley-Bixler syndrome?
Reardon, W., Smith, A., Honour, J. W., Hindmarsh, P., Das, D., Rumsby, G., Nelson, I., Malcolm, S., Adès, L., Sillence, D., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.1.26 · Cited by 123
Sharma, V. P., Wall, S. A., Lord, H., Lester, T., & Wilkie, A. O. M. (2012) · The Cleft Palate Craniofacial Journal · doi:10.1597/11-185 · Cited by 20
“The net effect of both types of mutation is to create an odd number of cysteines in the mutant monomer, promoting the formation of constitutively active covalent intermolecular dimers between two mutant molecules (Neilson and Friesel, 1995; Galvin et al., 1996).”
Background
Metadata
- Authors
- Galvin, B. D., Hart, K. C., Meyer, A. N., Webster, M. K., & Donoghue, D. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-07-23
- Volume
- 93
- Issue
- 15
- Pages
- 7894-7899
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1966665452
- Cited by
- 147
- References
- 1
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.